塩化パラフィンの生物の発生,蓄積,配置,および毒性の影響
Huiming Zhang1, Yutong Yang1, Mu Zhang1
1School of Public Health and Nursing, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China.
Environmental geochemistry and health
|February 19, 2026
まとめ
塩素パラフィン (CPs) は,世界的に見られる複雑な化学物質です. このレビューでは,それらの持続性,生物蓄積,野生生物と人間の健康に対する潜在的なリスクが強調され,継続的な環境モニタリングが必要とされています.
科学分野:
- 環境化学 環境化学
- 毒理学 毒理学 毒理学
- 生態毒理学 エコトキシコロジ
背景:
- 塩素パラフィン (CP) は,鎖の長さによって分類される合成アルカンである:短 (SCCP),中 (MCCP),長 (LCCP).
- その広範な使用,環境への持続性,および潜在的な毒性により,重大な懸念が生じています.
- CPsは,さまざまな物理化学的性質を持つ複雑な混合物です.
研究 の 目的:
- CPsの生産,排出,環境発生をレビューする.
- 様々な生物体におけるCPの生物蓄積,毒性動力学,および毒性を評価する.
- CPの環境への影響を理解するためのデータギャップを特定する.
主な方法:
- CPに関する既存の研究の文献レビュー.
- CPの生産,排出,環境濃度に関する報告されたデータの分析.
- CPsの発生,生物蓄積,および毒性に関する発見の統合.
主要な成果:
- CPsは世界中で検出され,水生生物や鳥類,特にアジアではSCCPとMCCPの濃度が高い.
- SCCPとMCCPの生物蓄積と生物増幅が食物網で示されている.
- 最近のデータは,CPが肝臓,腎臓,内分泌,免疫システム,胚の発達にリスクをもたらすことを示しています.
結論:
- CPの生産,排出,流通に関するデータには,その複雑さのために大きなギャップが存在します.
- CPsは持続的かつ生物蓄積性であり,生態系と人間の健康に長期的なリスクをもたらします.
- 継続的なモニタリングと評価は,CPの環境と健康への影響を管理するために不可欠です.
関連する概念動画
Types of Toxins
3.8K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.8K
Toxic Reactions: Overview
2.6K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
2.6K
Bioactivation and Tissue Toxicity
31
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
31
Toxicity Testing in Animals
34
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
34
Bioremediation
22.5K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
22.5K
Toxicokinetics: Overview
36
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
36


